过去一年中添加的文章,按日期排序

Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized ControlledTrial

LW Jones, CS Moskowitz, CP Lee, GA Fickera… - JAMA Oncology - jamanetwork.com
2 天前 - … A phase 2 randomized clinical trial has been initiated (NCT05751434) to investigate
the efficacy of longer-term exercise therapy at the RP2D on prostate cancer correlative end …

Tarlatamab: First Approval

S Dhillon - Drugs, 2024 - Springer
2 天前 - … of small cell lung cancer (SCLC) and neuroendocrine prostate cancer. Tarlatamab
binds … of response in the pivotal phase 2 DeLLphi-301 study, and continued approval may be …

[HTML][HTML] Stereotactic MR-guided daily adapted radiotherapy (SMART) for localised prostate cancer: Acute and late patient reported toxicity outcomes.

K Nugent, P Das, D Ford, A Sabharwal, C Perna… - Advances in Radiation …, 2024 - Elsevier
2 天前 - … The objective of this study is to report PROMs for gastrointestinal, genitourinary,
and … and late setting amongst patients who underwent SMART for localized prostate cancer. …

OPEN ACCESS EDITED BY

PE Spiess, E Shankar, K Takayama… - … Mechanism of Tumor …, 2024 - books.google.com
3 天前 - … of prostate cancer uncovered through scRNA-seq (Figure 1). By examining each
stage of prostate cancer … Moreover, another study involving seven patients with prostate cancer

RE:“Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement?”

H Daungsupawong, V Wiwanitkit - Prostate Cancer and Prostatic …, 2024 - nature.com
3 天前 - … In conclusion, the study provides a valuable assessment of ChatGPT 4.0+ in … in
future studies to enhance the validity and generalizability of the findings. Further research could …

[引用][C] Deciphering Disease Profiles in the Era of Prostate-Specific Membrane Antigen Positron Emission Tomography: Aggressive or Indolent?

PD Zang, S Jaime-Casas, W Yip - JCO Precision Oncology, 2024 - ascopubs.org
3 天前 - Biochemically recurrent (BCR) prostate cancer refers to … of patients with prostate
cancer after undergoing definitive … It is important to note that most of these studies used …

OPEN ACCESS EDITED BY

S Brogi, HM Mora-Montes, H Xin… - … and development of …, 2024 - books.google.com
4 天前 - … due to malaria or breast or prostate cancer (Brown et al., 2012… randomized,
double-blind, placebo-controlled clinical trial … aureus colonization: A phase 2 vaccine trial among …

Evaluating the effectiveness of cytoreductive surgery in oligometastatic prostate cancer: insights from quantitative analysis and retrospective cohort studies

B Cheng, B Li, J Fu, Q Wang, T Luo, Z Li… - International Journal of … - journals.lww.com
5 天前 - … In response to these complexities, our study is meticulously designed to provide a
prostate cancer. By integrating a quantitative analysis with a retrospective cohort study, we …

Pathologic and Short-Term Oncologic Outcomes of Prostate Cancer Patients Following Transvesical Robot-Assisted Radical Prostatectomy

T Benidir, EL Ferguson, Z Lone, NA Soputro… - … Oncology: Seminars and …, 2024 - Elsevier
5 天前 - … of clinical progression and prostate cancer-related mortality. … The strength of our
study is that this is the first study to our … our well-selected prostate cancer patients. By upholding …

[HTML][HTML] Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer

E Perez-Navarro, V Conteduca, JM Funes… - Cancers, 2024 - mdpi.com
6 天前 - … castration-resistant prostate cancer (mCRPC… study analyzed pre-treatment blood
samples from 152 chemotherapy-naive mCRPC patients participating in a phase 2 clinical trial